Global Personal Dosimeter Market Growth 2023-2029

Global Personal Dosimeter Market Growth 2023-2029

Dosimeters are devices used to measure the amount of energy deposited by ionising radiation. This measurement is used to estimate the effective dose received by the human body through exposure to external ionising radiation. Dosimeters are utilized in places where people deal with hazardous waste or radioactive substances, such as hospitals, nuclear power plant.

LPI (LP Information)' newest research report, the “Personal Dosimeter Industry Forecast” looks at past sales and reviews total world Personal Dosimeter sales in 2022, providing a comprehensive analysis by region and market sector of projected Personal Dosimeter sales for 2023 through 2029. With Personal Dosimeter sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Personal Dosimeter industry.

This Insight Report provides a comprehensive analysis of the global Personal Dosimeter landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Personal Dosimeter portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Personal Dosimeter market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Personal Dosimeter and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Personal Dosimeter.

The global Personal Dosimeter market size is projected to grow from US$ 231.4 million in 2022 to US$ 286.7 million in 2029; it is expected to grow at a CAGR of 286.7 from 2023 to 2029.

North America is the largest region of Personal Dosimeter, with a market share about 35%, followed by Europe and Asia-Pacific, etc. Mirion Technologies, Fuji Electric, Thermo Fisher Scientific, Aloka and Ludlum Measurements are the top 5 manufacturers of industry, and they had about 40% combined market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Personal Dosimeter market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Pen Dosimeters

Direct Read Electronic Dosimeters

Segmentation by application

Medical

Nuclear Power Plant

Industrial

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Mirion Technologies

Fuji Electric

Thermo Fisher Scientific

Aloka

Unfors RaySafe

RAE Systems

ATOMTEX

Ludlum Measurements

Saphymo

CIRNIC

Tracerco

Casella

Polimaster

Eckert & Ziegler

Biodex Medical Systems

Laurus

Arrow-Tech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Personal Dosimeter market?

What factors are driving Personal Dosimeter market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Personal Dosimeter market opportunities vary by end market size?

How does Personal Dosimeter break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.